Back to Rankings

MRK

MerckA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-15
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
MRK vs peer average
78/100
MRK vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 5 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

AZN is the first available peer comparator.

Large-cap global biopharma peer with similar scale and a broad oncology-heavy pipeline, useful for judging whether MRK deserves a premium for late-stage catalyst density versus concentration risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAZNAstraZeneca
MRK
Merck
AZN
AstraZeneca
Grade
A
F
Momentum
71
37
Value
65
62
Sentiment
57
6
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AZN

MRK / AZN
Grade Position
Above peers
MRK vs. peer average (A vs. C)
78/100
Momentum
71
MRK
Value
65
MRK
Sentiment
57
MRK

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MRK
1
AZN
AZN
F
20/100
+4
2
NVS
NVS
C
60/100
+2
3
REGN
REGN
C
60/100
+2
4
ABBV
AbbVie Inc Common
B
80/100
+1
5
NVO
Novo Nordisk A/S Class B ADR
B
80/100
+1
AZN is the first peer returned for this comparison set.